# FDA Inspection 1230725 - OneBlood, Inc. - February 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/2fa12d68-8fad-4dc7-8917-962353d7c623
Source feed: FDA_Inspections

> FDA Inspection 1230725 for OneBlood, Inc. on February 15, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230725
- Company Name: OneBlood, Inc.
- Inspection Date: 2024-02-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1088840 - 2019-05-02](https://www.keypedia.com/records/fda_inspections/oneblood-inc/7f12cc84-3742-42e4-b8e0-6e734a48e269)
- [FDA Inspection 1012420 - 2017-04-04](https://www.keypedia.com/records/fda_inspections/oneblood-inc/8603d37e-5358-443f-992a-be901a70aab9)
- [FDA Inspection 940840 - 2015-09-03](https://www.keypedia.com/records/fda_inspections/oneblood-inc/2d40e8a3-efca-4623-aae1-37ea34d9cec2)
- [FDA Inspection 822984 - 2013-03-08](https://www.keypedia.com/records/fda_inspections/oneblood-inc/89e42b40-33f1-4e9f-b77f-a30f0b86f600)
- [FDA Inspection 703057 - 2010-12-23](https://www.keypedia.com/records/fda_inspections/oneblood-inc/10b8df60-583b-4450-97eb-28159e80b1bc)

Company: https://www.keypedia.com/companies/oneblood-inc/4814b4d1-2b15-4e4e-a2e6-7f2900885fcc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d